JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110272200 on February 7, 2002

J. Biol. Chem., Vol. 277, Issue 16, 14216-14220, April 19, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/16/14216    most recent
M110272200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seo, E. J.
Right arrow Articles by Yu, M.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seo, E. J.
Right arrow Articles by Yu, M.-H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Concerted Regulation of Inhibitory Activity of alpha 1-Antitrypsin by the Native Strain Distributed throughout the Molecule*

Eun Joo Seo, Cheolju LeeDagger, and Myeong-Hee Yu§

From the National Creative Research Initiatives, Protein Strain Research Center, Korea Institute of Science and Technology, P. O. Box 131, Cheongryang, Seoul 130-650, Korea

Received for publication, October 25, 2001, and in revised form, February 5, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The native forms of common globular proteins are in their most stable state but the native forms of plasma serpins (serine protease inhibitors) show high energy state interactions. The high energy state strain of alpha 1-antitrypsin, a prototype serpin, is distributed throughout the whole molecule, but the strain that regulates the function directly appears to be localized in the region where the reactive site loop is inserted during complex formation with a target protease. To examine the functional role of the strain at other regions of alpha 1-antitrypsin, we increased the stability of the molecule greatly via combining various stabilizing single amino acid substitutions that did not affect the activity individually. The results showed that a substantial increase of stability, over 13 kcal mol-1, affected the inhibitory activity with a correlation of 11% activity loss per kcal mol-1. Addition of an activity affecting single residue substitution in the loop insertion region to these very stable substitutions caused a further activity decrease. The results suggest that the native strain of alpha 1-antitrypsin distributed throughout the molecule regulates the inhibitory function in a concerted manner.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The native forms of common globular proteins are in their most stable state and protein folding is a spontaneous process (1). However, the native forms of some proteins are not in their most stable state: typical examples are the strained native structure of plasma serpins1 (serine protease inhibitors) (2), the spring-loaded structure of the fusion protein of some viruses (3, 4), and heat shock transcription factors (5). The high energy state of the native structure of serpins is considered to be crucial to their physiological functions, such as plasma protease inhibition (1, 6), hormone delivery (7), Alzheimer filament assembly (8, 9), and extracellular matrix remodeling (10). The inhibition process of serpins can be described as a suicide substrate mechanism (11, 12), in which serpins, upon binding with proteases, partition between cleaved serpins (substrate pathway) and stable serpin-enzyme complexes (inhibitory pathway) as described in Scheme 1. 


View larger version (5K):
[in this window]
[in a new window]
 

<UP><SC>Scheme</SC> 1</UP>

In this scheme, I denotes the serpin; E, protease; EI, noncovalent Michaelis complex; E-I, a proposed intermediate prior to partitioning; E-I*, stable enzyme-inhibitor complex; and I*, cleaved serpin. The stoichiometry of inhibition (SI, the number of moles of inhibitors required to completely inhibit 1 mol of a target protease) is given by 1 + ksubstrate/kinhibition, in which ksubstrate and kinhibition are the rate constants for the substrate and inhibitory pathways, respectively. The crystal structure of a serpin-protease complex revealed that the reactive site loop of the serpin is cleaved and inserted into the major beta -sheet, sheet A, in the complex, whereas the target protease is attached to the cleaved loop of the serpin as an acyl intermediate (13). The conformational conversion during complex formation accompanies the distortion of the protease active site (13), which prevents catalytic deacylation and results in trapping the stabilized complex. Flexibility of the native serpin structure is required for conformational conversion, and the high energy state of the native conformation appears to be a driving force for this conversion.

To understand the structural basis and mechanistic consequences of the high energy state of native serpins, we have characterized stabilizing amino acid substitutions of human alpha 1-antitrypsin (alpha 1AT), a prototype serpin (14-18). In the crystal structure of the native alpha 1AT (19, 20), unfavorable interactions such as side chain overpacking, buried polar groups, internal cavities, and surface hydrophobic pockets occur (16, 17). These unfavorable interactions can be replaced by stabilizing substitutions (21, 22). We screened thermostable mutations over the entire alpha 1AT molecule and found stabilizing mutations that influence the flexibility of the native state distributed throughout the molecule (17). If the increase in the stability of the native state of alpha 1AT is manifested in the formation of the inhibitory complex, there should be a correlation between that increase in stability and the loss of inhibitory activity. Interestingly, however, only the stabilizing substitutions in the loop insertion region, such as Lys335 (23) and Gly117 (18) of sheet A, decreased the inhibitory activity, and the stabilizing mutations at most other sites of alpha 1AT did not cause the activity loss (17). It was shown recently that cavity filling substitutions designed at several sites of alpha 1AT increased the stability of the molecule, but activity affecting mutations among them were localized in the region that appears to be mobilized during the loop insertion (22). Thus, the high energy state in the loop insertion region appeared to be a nature's design for functional regulation but such a role of the strain at most other sites was not obvious. In the present study, we addressed this point by examining very stable mutations that were made through combining various single residue substitutions that did not affect the inhibitory activity individually. Characterization of the stable mutations suggests that the strain of alpha 1AT scattered over the molecule does regulate the inhibitory activity.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Chemicals-- Ultrapure guanidine hydrochloride was purchased from ICN Biochemicals, Inc. (Aurora, IL). Porcine pancreatic elastase (PPE), human leukocyte elastase (HLE), N-succinyl-(Ala)3-p-nitroanilide, and N-methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanilide were purchased from Sigma. All other chemicals were reagent grade.

Recombinant alpha 1AT Proteins-- The plasmid for alpha 1AT expression in Escherichia coli and the purification of recombinant proteins were described previously (14). Protein concentration was determined in 7 M guanidine hydrochloride, calculated from tyrosine and tryptophan content of the alpha 1AT protein (24). Amino acid substitutions at specific sites were generated by oligonucleotide-directed mutagenesis and confirmed by DNA sequencing. alpha 1AT cleaved at the reactive site loop was prepared by incubating with PPE at a molar ratio of 1:0.4 (alpha 1AT:protease) at 37 °C for 1 h in a buffer containing 50 mM Tris-HCl, 50 mM NaCl, pH 8.0. Phenylmethylsulfonyl fluoride was added at a final concentration of 1 mM to stop the reaction. Uncleaved molecules were removed by precipitating them at 70 °C for 15 min. The cleaved form was purified by ion exchange chromatography on MonoQ column in 10 mM phosphate, 1 mM beta -mercaptoethanol, 1 mM EDTA, pH 6.5. Cleavage of alpha 1AT was confirmed by 10% SDS-polyacrylamide gel electrophoresis and Coomassie Brilliant Blue staining.

Equilibrium Unfolding-- Equilibrium unfolding was carried out as a function of guanidine hydrochloride in 10 mM phosphate, 50 mM NaCl, and 1 mM EDTA, pH 6.5. The transition was monitored at 25 °C by change in fluorescence intensity (lambda ex = 280 nm, lambda em = 360 nm) on RF-5000 spectrofluorometer (Shimazu) or circular dichroism (CD) signal at 222 nm on Jasco-720 spectropolarimeter in 1-cm path length cell. The native protein was pre-equilibrated in the buffer containing various concentrations of guanidine hydrochloride at 25 °C for 4 h. The concentration of protein was 10 and 20 µg/ml for spectrofluorometry and CD spectroscopy, respectively. Equilibrium unfolding monitored by fluorescence change was fitted to a two-state model or three-state model and changes in the unfolding stability was determined according to Pace and co-workers (25). Briefly, it was calculated with the fitted thermodynamic parameters and the equation, Delta Delta G = <m> × Delta Cm, where Delta Cm is the difference between the values of Cm, equilibrium transition midpoint, for the wild type and mutant protein, and <m> is the average of the "m-value," a measure of the dependence of the free energy of unfolding (Delta G) on denaturant concentration. The <m> value used in the present study was 7.6 kcal mol-1 M-1.

Determination of the Inhibitory Activity-- The SI was determined as described (11). Various amounts of purified recombinant alpha 1AT proteins were incubated with 100 nM PPE or HLE at designated molar ratios of alpha 1AT to protease in 50 µl of assay buffer (30 mM phosphate, 160 mM NaCl, 0.1% PEG 8000, and 0.1% Triton X-100, pH 7.4). After incubation with the protease at 37 °C for 10 min, the reaction mixture was diluted 10-fold with the assay buffer and residual enzyme activity was determined. The active concentration of PPE was determined by measuring the initial rates of hydrolysis of 1 mM N-succinyl-(Ala)3-p-nitroanilide (26). The active concentration of HLE was determined as described previously (27) with trypsin-titrated human plasma alpha 1AT and a substrate, N-methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanilide. The activity inhibition was extrapolated to yield the minimum molar ratio of alpha 1AT to the protease giving 100% inhibition. The association rate constant for the interaction of recombinant alpha 1AT with PPE was measured under second order conditions (28) in a reaction mixture containing equimolar concentrations (8 nM) of the protease and the inhibitor.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Conformational Properties of Stable alpha 1AT Variants-- Stable alpha 1AT variants were constructed by combining various single residue substitutions that increased conformational stability without diminishing the inhibitory activity (Fig. 1, colored cyan). Each component substitutions of alpha 1AT are located at various secondary structures (helix A, helix B, helix C, helix H, helix F, and the following loop, helix I and the following loop, strand 3 of beta -sheet A, strands 2-6 of beta -sheet B, and strands 1 and 2 of beta -sheet C). Fig. 2A shows the unfolding transition of several alpha 1AT variants in the presence of guanidine hydrochloride, which was monitored by the change in intrinsic fluorescence intensity. By combining various stabilizing substitutions of alpha 1AT, the midpoint of unfolding transition (Cm) could be increased up to 3.29 from 0.65 M, the wild type value. The stabilizing effects of various combinations are summarized in Table I. The stability of M16 alpha 1AT molecule that was cleaved in the reactive site loop was comparable to that of the cleaved wild type (Fig. 2A, filled symbols, Cm of 6.24 versus 5.91 M). The stability of other cleaved mutant alpha 1AT was also comparable. When the unfolding transition was monitored by CD spectrometry, the wild type and M7 alpha 1AT showed biphasic transitions (Fig. 2B), in which the transition at the lower denaturant concentration appeared to coincide with the transition monitored by fluorescence intensity (Fig. 2B, dotted lines). The unfolding transition of M13 and M16 monitored by CD showed single transitions with the mid-point of 2.66 and 3.29 M, respectively (Fig. 2B), which are superimposable with the unfolding transitions monitored by fluorescence (dotted lines).


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 1.   A stereo diagram of alpha 1AT showing individual amino acid substitutions in combinatorial mutations. The atomic coordinates for the crystal structure of native alpha 1AT were taken from the structure (PDB code: 1HP7) that was reported recently (20). The substitution sites are depicted by beads. The site of the activity affecting substitution, K335V, is colored red. The reactive site loop is represented in green, and the region mobilized upon insertion of the reactive site loop (s3A, s5A, hF, and the following loop) is represented in yellow. The figures were prepared with MOLSCRIPT (37).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   Guanidine hydrochloride-induced unfolding transition of the variant alpha 1AT carrying combinatorial mutations. A, unfolding was monitored by the increase in fluorescence emission intensity at 360 nm (lambda ex = 280 nm). Samples (10 µg/ml) were incubated in guanidine hydrochloride solution of 10 mM potassium phosphate, 50 mM NaCl, 1 mM EDTA, 1 mM beta -mercaptoethanol, pH 6.5, at 25 °C for 4 h. The data were fitted to a two-state unfolding model. open circle , native wild-type; , native M7; Delta , native M13; down-triangle, native M16; , cleaved wild-type; black-down-triangle , cleaved M16. B, unfolding of the native form was measured by the loss of CD ellipticity at 222 nm. The protein concentration was 20 µg/ml. open circle , wild type; , M7; Delta , M13; down-triangle, M16. The data of the wild type and M7 were fitted to a three-state unfolding model, and those of M13 and M16 were fitted to a two-state unfolding model. The dotted lines exhibit the fitted two-state unfolding monitored by fluorescence intensity.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Molecular properties of multiple stabilizing mutations of alpha 1AT

Inhibitory Function of Stable alpha 1AT Variants-- To investigate the effect of the stabilizing mutations on the inhibitory activity of alpha 1AT, the SI value of the variants alpha 1AT toward HLE was measured. Fig. 3 shows that M13, M14b, and M16, but not M7, increased the SI, and the degree of increase correlated with the stability increase. The SI values of other variants alpha 1AT are summarized in Table I. Table I also shows the mutational effect on the inhibitory activity that was obtained from the SI values of the wild type and the variant alpha 1AT (relative activity). When the SI values toward PPE were measured for several variant forms of alpha 1AT, similar degrees of activity decrease were observed (data not shown). Table I also shows the ratios of partitioning between the substrate and inhibitory pathways (ksubstrate over kinhibition) for each variant alpha 1AT, which were obtained from the SI values (SI-1). When the wild-type alpha 1AT interacts with HLE, the partitioning ratio is close to 0 because most of alpha 1AT molecules form the inhibitory complex. The stable mutation, M16, increased this ratio up to 10, which indicates that less than 10% of the mutant molecules formed the inhibitory complex and the rest were cleaved by HLE. The association rate constant (ka) of the variants alpha 1AT with PPE did not differ significantly from the wild type value, 5.5 × 105 M-1 s-1 (data not shown). The association rate with HLE was over 107 M-1 s-1 and could not be determined precisely.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Inhibitory activity of variant alpha 1AT carrying combinatorial mutations. The SI values of representative alpha 1AT variants against HLE were determined. open circle , wild-type; , M7; Delta , M13; diamond , M14b; down-triangle, M16. HLE (100 nM) was incubated with various alpha 1AT concentrations at designated molar ratios ([inhibitor])/[HLE]) indicated at the abscissa. The lowest value of [inhibitor]/[HLE] giving 100% inhibition is the estimated stoichiometry of inhibition.

Combination of the Multiple Stabilizing Substitutions with Activity Affecting Single Residue Substitution-- Some of the previously identified single residue substitutions caused activity decrease although they increased the stability much less than M7 did. To examine if the stable multiple substitutions constructed in the present study affect the inhibitory activity in a similar way to that of the previously identified activity affecting single residue substitutions, K335V (Fig. 1, colored red) was combined with M5b, M7, and M14a. Table II shows that the combinations increased the stability as much as expected from the sum of individual effects, and decreased the inhibitory activity more than K335V.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Combination of multiple stabilizing mutations and activity-affecting single mutation


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We examined the combinatorial effect of the stabilizing substitutions of alpha 1AT that did not affect the activity individually. Loss of inhibitory activity was observed with the current set of the stabilizing mutations only when the stability increase was substantial (Table I). In Fig. 4, correlation between the stability increase of alpha 1AT and the decrease in the inhibition toward HLE was examined (filled circles). Any significant decrease in activity was not observed with the stability increase up to 13 kcal mol-1, but the activity leveled off as the stability increased further with a correlation of about 11% activity loss per kcal mol-1. This degree of activity reduction toward HLE was approximately similar to that toward PPE (data not shown). These results clearly showed that a substantial stability increase by the multiple substitutions could also affect the inhibitory function of alpha 1AT, although each component substitution has inert effect on the activity. The results suggest that high energy states of alpha 1AT distributed throughout the molecule regulate inhibitory function in a collective manner. Some single residue substitutions in the loop insertion region, such as those at Gly117 or Lys335 site, increased the stability up to 6 kcal mol-1 with a concomitant decrease in the inhibitory activity (16-18, 22). Gly117 and Lys335 sites lie beneath helix F and the following loop that cover beta -sheet A at the bottom half in the loop insertion region (Fig. 1), and flexibility in this region appears to be critical for the loop insertion during the complex formation. Since simultaneous stabilization at many other sites throughout the molecule is as detrimental as the stabilization in the loop insertion region (Table I), flexibility throughout the alpha 1AT molecule may also be critical for the complex formation.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 4.   Correlation between stability and inhibitory activity of alpha 1AT. The values of relative activity toward HLE are plotted as a function of Delta Delta G. , multiple combination mutations in Table I; Delta , K335V, K335 + M5b, K335V + M7, K335V + M14a in Table II in the order of increasing stability. The dotted line represents the best fit of the stability activity correlation among the activity affecting combinatorial mutations.

Regulation of Inhibitory Activity by the Conformational Properties of alpha 1AT-- Various studies suggested that rapid loop insertion in a serpin (12, 29-32) and active site distortion of the protease (13, 33) confer inhibitory activity on the serpins. Experimental data showed a direct correlation between retardation of the loop insertion and the activity decrease (15, 34). The stability increase in the current set of mutant proteins may also influence the complex formation by retarding the loop insertion. Why then is the activity affected only when the stability increase is over 13 kcal mol-1? Unfolding of the wild type alpha 1AT is biphasic, as probed by CD signal, although the change in fluorescence intensity monitors only the first transition (Fig. 2). Very stable variants that decreased the inhibitory activity such as M13 and M16 showed a single superimposable unfolding transition, whereas M7, which did not affect the activity, showed biphasic transition (Fig. 2B). Biphasic transition of equilibrium unfolding indicates that the molecule is made of two folding domains. The intrinsic fluorescence change monitors the environmental change near Trp194 (35), the unique buried tryptophan residue at the top of strand 3 of sheet A. It is very likely that equilibrium fluorescence change reflects initial opening of sheet A, and unfolding of alpha 1AT can be considered as opening of sheet A followed by further unfolding of the remaining secondary structures. For those mutations that show a single transition, opening of sheet A appear to be coupled with complete unfolding. It may be that such conformation property of alpha 1AT as domain folding is important for proper complex formation with a target protease. There is another possibility that the energy difference between the strained native state and a more stable state in the complex becomes too small to trap the protease-inhibitor complex as an acyl-enzyme inhibitor. It was suggested that the energy difference is utilized for trapping the protease-inhibitor complex (32, 36), presumably by distorting the protease active site (13). If the difference becomes too small, the proposed distortion and trapping may become inefficient. Further studies will elucidate detailed mechanisms how the stability of a serpin molecule regulates its inhibitory activity.

Concerted Regulation of the Inhibitory Function by the Native Strain-- We examined how the stable multiple substitutions constructed in the current study might influence the activity affecting single residue substitutions. The activity of K335V decreased further down when a multiple substitution, such as M5, M7, or M14, was combined (Table II; Fig. 4, open symbols). The results suggest that at least two distinct steps are involved in the regulation of the complex formation. The first step appears to be the destabilization of the interactions between helix F and sheet A, which is affected by the activity affecting single residue substitutions in this region (e.g. K335V) but not by such multiple stable substitutions as M5 or M7. The step is likely to be independent of the changes in fluorescence property and secondary structure contents. However, the activity affecting single residue substitutions also shift the unfolding midpoints monitored by fluorescence and CD signals with a good correlation with the activity decrease (16, 18). Therefore, the step is likely to be prerequisite to opening of sheet A detected by fluorescence and CD. The second step is opening of beta -sheet A for the insertion and locking of the reactive site loop. This step appears to require flexibility of the whole molecule, because the inhibitory activity is affected when the step is coupled with global stability as with the very stable multiple substitutions. Whereas the interactions at specific location are important in the first step, collective molecular properties may be as important in the second step. Our results clearly suggest that high energy states of alpha 1AT regulate concertedly various steps of the complex formation.

In summary, we probed the functional role of the native strain of alpha 1AT that is distributed throughout the molecule. Although stability of the wild type alpha 1AT is optimized and is designed in such a way that the activity is not sensitive to a minor change in the stability, a substantial stability increase of alpha 1AT affected the inhibitory activity of the molecule. The opening of sheet A, a critical step for the loop insertion, appears to be regulated by such conformational properties as domain folding and global stability as well as local high-energy states in the loop insertion region.

    FOOTNOTES

* This work was supported by a National Creative Research Initiatives grant from the Korean Ministry of Science and Technology.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Present address: Korea Research Institute of Bioscience and Biotechnology, P. O. Box 115 Yusong, Taejon 305-600, Korea.

§ To whom correspondence should be addressed. Tel.: 82-2-958-6911; Fax: 82-2-958-6919; E-mail: mhyu@.kist.re.kr.

Published, JBC Papers in Press, February 7, 2002, DOI 10.1074/jbc.M110272200

    ABBREVIATIONS

The abbreviations used are: serpin, serine protease inhibitor; alpha 1AT, alpha 1-antitrypsin; PPE, porcine pancreatic elastase; HLE, human leukocyte elastase; SI, stoichiometry of inhibition.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Anfinsen, C. B. (1973) Science 181, 223-230[Free Full Text]
2. Huber, R., and Carrell, R. W. (1989) Biochemistry 28, 8951-8966[CrossRef][Medline] [Order article via Infotrieve]
3. Carr, C. M., and Kim, P. S. (1993) Cell 73, 823-832[CrossRef][Medline] [Order article via Infotrieve]
4. Chan, D. C., Fass, D., Berger, J. M., and Kim, P. S. (1997) Cell 89, 263-273[CrossRef][Medline] [Order article via Infotrieve]
5. Orosz, A., Wisniewski, J., and Wu, C. (1996) Mol. Cell. Biol. 16, 7018-7030[Abstract]
6. Stein, P. E., and Carrell, R. W. (1995) Nat. Struct. Biol. 2, 96-113[CrossRef][Medline] [Order article via Infotrieve]
7. Pemberton, P. A., Stein, P. E., Pepys, M. B., Potter, J. M., and Carrell, R. W. (1988) Nature 336, 257-258[CrossRef][Medline] [Order article via Infotrieve]
8. Ma, J., Yee, A., Brewer, H. B., Jr., Das, S., and Potter, H. (1994) Nature 372, 92-94[CrossRef][Medline] [Order article via Infotrieve]
9. Abraham, C. R., Selkoe, D. J., and Potter, H. (1988) Cell 52, 487-501[CrossRef][Medline] [Order article via Infotrieve]
10. Stefansson, S., and Lawrence, D. A. (1996) Nature 383, 441-443[CrossRef][Medline] [Order article via Infotrieve]
11. Rubin, H., Wang, Z.-M., Nickbarg, E. B., McLarney, S., Naidoo, N., Schoenberger, O. L., Johnson, J. L., and Cooperman, B. S. (1990) J. Biol. Chem. 265, 1199-1207[Abstract/Free Full Text]
12. Wright, H. T., and Scarsdale, J. N. (1995) Proteins Struct. Funct. Genet. 22, 210-225[CrossRef][Medline] [Order article via Infotrieve]
13. Huntington, J. A., Read, R. J., and Carrell, R. W. (2000) Nature 407, 923-926[CrossRef][Medline] [Order article via Infotrieve]
14. Kwon, K.-S., Kim, J., Shin, H. S., and Yu, M.-H. (1994) J. Biol. Chem. 269, 9627-9731[Abstract/Free Full Text]
15. Lee, K. N., Park, S. D., and Yu, M.-H. (1996) Nat. Struct. Biol. 3, 497-500[CrossRef][Medline] [Order article via Infotrieve]
16. Im, H., Seo, E. J., and Yu, M.-H. (1999) J. Biol. Chem. 274, 11072-11777[Abstract/Free Full Text]
17. Seo, E. J., Im, H., Maeng, J.-S., Kim, K. E., and Yu, M.-H. (2000) J. Biol. Chem. 275, 16904-16909[Abstract/Free Full Text]
18. Lee, C., Park, S.-H., Lee, M.-Y., and Yu, M.-H. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 7727-7731[Abstract/Free Full Text]
19. Elliott, P. R., Abrahams, J.-P., and Lomas, D. A. (1998) J. Mol. Biol. 275, 419-425[CrossRef][Medline] [Order article via Infotrieve]
20. Kim, S.-J., Woo, J.-R., Seo, E. J., Yu, M.-H., and Ryu, S.-E. (2001) J. Mol. Biol. 306, 109-119[CrossRef][Medline] [Order article via Infotrieve]
21. Ryu, S.-E., Choi, H.-J., Kwon, K.-S., Lee, K. N., and Yu, M.-H. (1996) Structure 4, 1181-1192[Medline] [Order article via Infotrieve]
22. Lee, C., Maeng, J.-S., Kocher, J.-P., Lee, B., and Yu, M.-H. (2001) Protein Sci. 10, 1446-1453[Abstract/Free Full Text]
23. Im, H., and Yu, M.-H. (2000) Protein Sci. 9, 934-941[Abstract]
24. Edelhoch, H. (1967) Biochemistry 6, 1948-1954[CrossRef][Medline] [Order article via Infotrieve]
25. Pace, C. N., Shirley, B. A., and Thomson, J. A. (1989) in Protein Structure: A Practical Approach (Creighton, T. E., ed) , pp. 311-330, IRL Press, New York
26. Hopkins, P. C. R., Carrell, R. W., and Stone, S. R. (1993) Biochemistry 32, 7650-7657[CrossRef][Medline] [Order article via Infotrieve]
27. Rubin, H., Plotnick, M., Wang, Z.-M., Liu, X., Zhong, Q., Schechter, N. M., and Cooperman, B. S. (1994) Biochemistry 33, 7627-7633[CrossRef][Medline] [Order article via Infotrieve]
28. Beatty, K., Bieth, J., and Travis, J. (1980) J. Biol. Chem. 255, 3931-3934[Abstract/Free Full Text]
29. Shore, J. D., Day, D. E., Francis-Chmura, A. M., Verhamme, I., Kvassman, J., Lawrence, D. A., and Ginsburg, D. A. (1995) J. Biol. Chem. 270, 5395-5398[Abstract/Free Full Text]
30. Engh, R. A., Huber, R., Boed, W., and Schulze, A. J. (1995) Trends Biotechnol. 13, 503-510[CrossRef][Medline] [Order article via Infotrieve]
31. Wright, H. T. (1998) BioEssays 18, 453-464
32. Silverman, G. A., Bird, P. I., Carrell, R. W., Church, F. C., Coughlin, P. B., Gettins, P. G., Irving, J. I., Lomas, D. A. W., Luke, C. J., Moyer, R. W., Pemberton, P. A., Remold-O'Donnell, E., Salvesen, G. S., Travis, J., and Whisstock, J. C. (2001) J. Biol. Chem. 276, 33293-33296[Free Full Text]
33. Plotnick, M. I., Mayne, L., Schechter, N. M., and Rubin, H. (1996) Biochemistry 35, 7586-7590[CrossRef][Medline] [Order article via Infotrieve]
34. Lawrence, D. A., Olson, S. T., Muhammad, S., Day, D. E., Kvassman, J., Ginsburg, D. A., and Shore, J. D. (2000) J. Biol. Chem. 275, 5839-5844[Abstract/Free Full Text]
35. Kim, D., and Yu, M.-H. (1996) Biochem. Biophys. Res. Commun. 226, 378-384[CrossRef][Medline] [Order article via Infotrieve]
36. Loebermann, H., Tokuoka, R., Deisenhofer, J., and Huber, R. (1984) J. Mol. Biol. 177, 531-556[CrossRef][Medline] [Order article via Infotrieve]
37. Kraulis, P. J. (1991) J. App. Crystallogr. 24, 946-950[CrossRef]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Sci.Home page
L. Liu, N. Mushero, L. Hedstrom, and A. Gershenson
Short-lived protease serpin complexes: Partial disruption of the rat trypsin active site
Protein Sci., November 1, 2007; 16(11): 2403 - 2411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. F. Fulton, A. M. Buckle, L. D. Cabrita, J. A. Irving, R. E. Butcher, I. Smith, S. Reeve, A. M. Lesk, S. P. Bottomley, J. Rossjohn, et al.
The High Resolution Crystal Structure of a Native Thermostable Serpin Reveals the Complex Mechanism Underpinning the Stressed to Relaxed Transition
J. Biol. Chem., March 4, 2005; 280(9): 8435 - 8442.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/16/14216    most recent
M110272200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seo, E. J.
Right arrow Articles by Yu, M.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seo, E. J.
Right arrow Articles by Yu, M.-H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.